Medicine and Dentistry
Patient
100%
Therapeutic Procedure
93%
Mucosal Melanoma
57%
Neoplasm
50%
Diseases
45%
Lung Cancer
43%
Non Small Cell Lung Cancer
32%
Immunotherapy
30%
Targeted Therapy
26%
Inpatient
25%
Volatile Organic Compound
24%
Uveal Melanoma
24%
Male
24%
Malignant Neoplasm
24%
Overall Survival
22%
Receptor
21%
Receptor Expression
20%
Osteosarcoma
19%
Cystadenoma
19%
Kidney Carcinoma
19%
Lung Nodule
19%
Clear Cell Renal Cell Carcinoma
19%
Kidney Metastasis
19%
Clinical Trial
19%
Metastatic Uvea Melanoma
19%
Multimodality Imaging
19%
Clinical Feature
19%
Cytotoxic Chemotherapy
19%
Finger Dermatoglyphics
19%
Somatomedin
19%
Breath Analysis
19%
Monoclonal Antibody
19%
Cancer Cell
19%
Gastrin Releasing Peptide Receptor
19%
Cancer
18%
Development
18%
Quality of Life
16%
Surgery
15%
Death
15%
Progression Free Survival
15%
Breathing
14%
Combination Therapy
14%
Cutaneous Melanoma
13%
Cell Membrane
12%
Biological Product
12%
Nodular Melanoma
11%
Prognosis
11%
Small Cell Lung Cancer
10%
Tissues
10%
Diagnosis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
38%
Uvea Melanoma
24%
Receptor
21%
Lung Cancer
19%
Kidney Carcinoma
19%
Kidney Metastasis
19%
Anticarcinogen
19%
Eye Melanoma
19%
Metastatic Uvea Melanoma
19%
Renal Cell Carcinoma
19%
Somatomedin
19%
Gastrin Releasing Peptide Receptor
19%
Overall Survival
15%
Progression Free Survival
15%
Neoplasm
14%
Diseases
13%
Drug
12%
Biological Product
12%
Non Small Cell Lung Cancer
10%
Malignant Neoplasm
10%
Immunotherapy
9%
Small Cell Lung Cancer
8%
Adverse Event
8%
Melanoma
7%
Lymphoma
6%
Trabectedin
6%
Solid Malignant Neoplasm
5%
Adenocarcinoma
5%
Toxicity
5%
Metastasis
5%
